Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden
· Delayed Price · Currency is SEK 4.245
-0.315 (-6.91%)
Jun 17, 2025, 5:29 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 1.64 billion as of June 17, 2025. Its market cap has decreased by -31.97% in one year.
Market Cap
1.64B
Enterprise Value
1.47B
Revenue
46.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.25
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 1.64B, an increase of 628.41%. That is a compound annual growth rate of 15.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 99.12B |
| Sectra AB | 60.46B |
| Getinge AB | 51.21B |
| Asker Healthcare Group AB | 41.61B |
| Medicover AB | 36.39B |
| Camurus AB | 35.50B |
| AddLife AB | 24.19B |
| Vimian Group AB | 20.64B |